Andy Camenisch

Patent Director

Andy specialises primarily in patents in the fields of pharmaceuticals and chemistry on inventions relating to new chemical entities (NCEs), pharmaceutical formulations, methods of treatment, dosing regimens, medical devices, methods of manufacture, food and beverage products, materials chemistry and cosmetics products. 

As well as drafting and prosecuting patent applications, Andy is also experienced in pharmaceutical patent litigation, having been involved in revocation proceedings at the UK High Court and also in the coordination of the pan-European revocation of a number of European patents covering pharmaceutical formulations and drug combinations.

Andy also manages the delivery of due diligence projects, requiring the formulation of complex prior art and FTO search strategies and advising on issues relating to patent term extensions, SPCs, regulatory data exclusivity, the enforceability of the patent portfolio (e.g. in terms of its patentability) and freedom to operate. 

Andy’s client base includes International pharmaceutical companies, cosmetic companies and bulk chemical companies and UK Universities.

Andy graduated from The University of Nottingham with a first class MSc degree in Chemistry in 2006, joining the patent profession straight from University.  He qualified as both a UK Chartered Patent Attorney and European Patent Attorney in 2010.


Learn more about Andy's experience at HGF here